Intratympanic steroid injection versus hyperbaric oxygen therapy in refractory sudden sensorineural hearing loss: a meta-analysis
- PMID: 33751195
- DOI: 10.1007/s00405-021-06616-9
Intratympanic steroid injection versus hyperbaric oxygen therapy in refractory sudden sensorineural hearing loss: a meta-analysis
Abstract
Objective: The present meta-analysis aims to compare the efficacy of intratympanic steroid (ITS) injection and hyperbaric oxygen (HBO) therapy as salvage treatments for refractory sudden sensorineural hearing loss (SSNHL).
Data sources: Comprehensive searches were performed in PubMed, EMBASE and the Cochrane Library from the date of the database inception to June 2020. All studies reporting the use of salvage ITS and HBO treatments in refractory SSNHL patients were included. Subsequently, the full texts of the eligible studies were evaluated.
Methods: The quality and bias of the studies were assessed using the Newcastle-Ottawa Scale and Cochrane's risk of bias tools for nonrandomized and randomized studies, respectively. The data were analyzed using Comprehensive Meta-Analysis software (Version 3; Biostat, Englewood, NJ).
Results: Three hundred and fourteen subjects in 3 observational studies and 1 randomized controlled trial met our inclusion criteria. The pooled results demonstrated that there were no significant differences in the mean posttreatment hearing gain between the ITS and HBO groups. The changes in word discrimination and hearing gain at 250, 500, 1000, 2000, 4000 and 8000 Hz were also comparable between the two salvage treatment groups.
Conclusions: The pooled results demonstrated that there were no significant differences in hearing improvements between salvage ITS injection and salvage HBO therapy after failed primary systemic steroid treatment in patients with SSNHL. However, spontaneous recovery could bias the treatment outcomes, and these results should be interpreted with caution. Clinicians may choose these salvage treatments according to personal experience and treatment availability. In cases in which specialized HBO facilities are difficult to access, salvage ITS injection can be provided with comparable responses.
Keywords: Hyperbaric oxygen therapy; Intratympanic steroids; Refractory sudden hearing loss; Salvage treatment; Sudden sensorineural hearing loss.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Hyperbaric Oxygen Therapy Versus Intratympanic Steroid for Salvage Treatment of Sudden Sensorineural Hearing Loss: A Systematic Review and Meta-analysis.Otol Neurotol. 2021 Sep 1;42(8):e980-e986. doi: 10.1097/MAO.0000000000003198. Otol Neurotol. 2021. PMID: 34172651
-
Comparison of intratympanic steroid injection, hyperbaric oxygen and combination therapy in refractory sudden sensorineural hearing loss.Otol Neurotol. 2013 Oct;34(8):1411-6. doi: 10.1097/MAO.0b013e3182a1eb83. Otol Neurotol. 2013. PMID: 24005170
-
Intratympanic steroid therapy as a salvage treatment for sudden sensorineural hearing loss after failure of conventional therapy: a meta-analysis of randomized, controlled trials.Clin Ther. 2015 Jan 1;37(1):178-87. doi: 10.1016/j.clinthera.2014.11.009. Epub 2014 Dec 24. Clin Ther. 2015. PMID: 25542075
-
Salvage therapy for refractory sudden sensorineural hearing loss (RSSNHL): a systematic review and network meta-analysis.Int J Audiol. 2025 Jan;64(1):1-10. doi: 10.1080/14992027.2024.2303037. Epub 2024 Jan 22. Int J Audiol. 2025. PMID: 38251843
-
Addition of intratympanic steroid or hyperbaric oxygen treatment to systemic steroid treatment in sudden idiopathic sensorineural hearing loss treatment, and long-term results of salvage treatment.Turk J Med Sci. 2020 Feb 13;50(1):177-183. doi: 10.3906/sag-1908-122. Turk J Med Sci. 2020. PMID: 31865663 Free PMC article.
Cited by
-
Idiopathic sudden sensorineural hearing loss: effectiveness of salvage treatment with intratympanic dexamethasone or hyperbaric oxygen therapy in addition to systemic steroids.Front Neurol. 2023 Aug 25;14:1225206. doi: 10.3389/fneur.2023.1225206. eCollection 2023. Front Neurol. 2023. PMID: 37693762 Free PMC article.
-
Hyperbaric Oxygen Therapy in the Treatment of Sudden Sensorineural Hearing Loss.J Clin Med. 2023 Feb 14;12(4):1515. doi: 10.3390/jcm12041515. J Clin Med. 2023. PMID: 36836049 Free PMC article.
-
Evaluating hyperbaric oxygen therapy as an adjunct to corticosteroids in sudden sensorineural hearing loss: a systematic review and meta-analysis.Eur Arch Otorhinolaryngol. 2025 May 22. doi: 10.1007/s00405-025-09372-2. Online ahead of print. Eur Arch Otorhinolaryngol. 2025. PMID: 40405024 Review.
-
Salvage treatment strategies for refractory sudden sensorineural hearing loss-a comprehensive review and meta-analysis with practical recommendations.Front Neurol. 2025 Jul 15;16:1627892. doi: 10.3389/fneur.2025.1627892. eCollection 2025. Front Neurol. 2025. PMID: 40734818 Free PMC article.
-
Current Role of the Nonsteroid Treatment of Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL): A Narrative Review.J Clin Med. 2025 Apr 18;14(8):2811. doi: 10.3390/jcm14082811. J Clin Med. 2025. PMID: 40283640 Free PMC article. Review.
References
-
- Stachler RJ, Chandrasekhar SS, Archer SM et al (2012) Clinical practice guideline: sudden hearing loss. Otolaryngol-Head Neck Surg 146(3_suppl):S1–S35 - DOI
-
- Seggas I, Koltsidopoulos P, Bibas A, Tzonou A, Sismanis A (2011) Intratympanic steroid therapy for sudden hearing loss: a review of the literature. Otol Neurotol 32(1):29–35 - DOI
-
- Battaglia A, Burchette R, Cueva R (2008) Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss. Otol Neurotol 29(4):453–460 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous